See more : CPH Chemie + Papier Holding AG (0QNZ.L) Income Statement Analysis – Financial Results
Complete financial analysis of Healthcare Co., Ltd. (603313.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Healthcare Co., Ltd., a leading company in the Furnishings, Fixtures & Appliances industry within the Consumer Cyclical sector.
- Advance Syntex Limited (ASYL.BO) Income Statement Analysis – Financial Results
- Bairong Inc. (6608.HK) Income Statement Analysis – Financial Results
- Bengang Steel Plates Co., Ltd. (000761.SZ) Income Statement Analysis – Financial Results
- CLSA Premium Limited (6877.HK) Income Statement Analysis – Financial Results
- Bleecker Société Anonyme (BLEE.PA) Income Statement Analysis – Financial Results
Healthcare Co., Ltd. (603313.SS)
Industry: Furnishings, Fixtures & Appliances
Sector: Consumer Cyclical
Website: https://www.hkfoam.com
About Healthcare Co., Ltd.
Healthcare Co., Ltd. manufactures and sells memory foam products in China. The company provides foam toppers, mattresses, sofas, and pillows. It also sells its products under the MLILY brand through company-owned retail shops. The company also exports its products to Europe, Russia, the Middle East, and North Africa. Healthcare Co., Ltd. was founded in 2003 and is based in Rugao, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.98B | 8.02B | 8.14B | 6.53B | 3.83B | 3.05B | 2.34B | 1.72B | 1.38B | 1.16B | 955.81M | 899.84M | 673.94M |
| Cost of Revenue | 4.92B | 5.53B | 5.82B | 4.32B | 2.31B | 2.07B | 1.65B | 1.14B | 897.17M | 813.03M | 660.51M | 621.45M | 467.70M |
| Gross Profit | 3.06B | 2.49B | 2.32B | 2.21B | 1.52B | 978.35M | 690.85M | 578.97M | 480.05M | 349.12M | 295.29M | 278.39M | 206.24M |
| Gross Profit Ratio | 38.35% | 31.04% | 28.47% | 33.92% | 39.72% | 32.08% | 29.54% | 33.60% | 34.86% | 30.04% | 30.89% | 30.94% | 30.60% |
| Research & Development | 115.66M | 95.31M | 124.25M | 110.16M | 101.23M | 88.85M | 80.13M | 52.91M | 43.89M | 39.79M | 29.20M | 27.86M | 0.00 |
| General & Administrative | 242.70M | 251.48M | 303.86M | 244.35M | 118.58M | 78.06M | 57.39M | 39.06M | 36.30M | 20.14M | 18.84M | 70.46M | 53.82M |
| Selling & Marketing | 1.19B | 1.44B | 1.31B | 881.53M | 624.53M | 401.06M | 282.41M | 193.02M | 156.96M | 94.82M | 75.39M | 58.65M | 43.09M |
| SG&A | 1.44B | 1.69B | 1.62B | 1.13B | 743.11M | 479.12M | 339.80M | 232.08M | 193.26M | 114.96M | 94.23M | 129.11M | 96.91M |
| Other Expenses | 0.00 | 397.20M | 367.33M | 205.33M | 105.66M | -28.40M | 727.48K | 20.19M | -56.83K | -7.51K | 3.52M | 6.35M | 3.63M |
| Operating Expenses | 2.89B | 2.18B | 2.11B | 1.44B | 949.99M | 652.80M | 469.69M | 352.94M | 289.75M | 195.04M | 155.18M | 135.44M | 98.81M |
| Cost & Expenses | 7.81B | 7.71B | 7.93B | 5.76B | 3.26B | 2.72B | 2.12B | 1.50B | 1.19B | 1.01B | 815.69M | 756.89M | 566.50M |
| Interest Income | 3.63M | 1.31M | 2.94M | 12.13M | 6.58M | 3.60M | 5.31M | 1.97M | 177.21K | 182.02K | 141.31K | 2.90M | -0.75 |
| Interest Expense | 337.84M | 182.32M | 140.52M | 80.26M | 43.45M | 26.85M | 11.85M | 5.33M | 4.94M | 2.74M | 3.25M | 0.00 | 8.93M |
| Depreciation & Amortization | 505.67M | 541.92M | 439.08M | 200.14M | 109.07M | 58.63M | 47.67M | 30.79M | 21.22M | 15.69M | 14.03M | 10.02M | 22.68M |
| EBITDA | 884.17M | 918.51M | 355.09M | 830.94M | 613.70M | 332.36M | 246.21M | 279.22M | 220.56M | 167.62M | 147.41M | 142.95M | 114.31M |
| EBITDA Ratio | 11.09% | 9.80% | 4.36% | 10.77% | 17.02% | 11.16% | 10.66% | 16.25% | 16.46% | 14.66% | 15.65% | 15.87% | 16.96% |
| Operating Income | 482.90M | 341.99M | -4.97M | 515.28M | 496.00M | 241.75M | 183.89M | 225.78M | 193.10M | 147.05M | 127.09M | 132.79M | 91.64M |
| Operating Income Ratio | 6.05% | 4.27% | -0.06% | 7.89% | 12.94% | 7.93% | 7.86% | 13.10% | 14.02% | 12.65% | 13.30% | 14.76% | 13.60% |
| Total Other Income/Expenses | -318.44M | -175.99M | -269.19M | -40.68M | -2.68M | -56.13M | -603.92K | 13.46M | 3.40M | -5.26M | -5.19M | -4.83M | 3.61M |
| Income Before Tax | 164.47M | 81.37M | -274.16M | 474.59M | 493.32M | 241.71M | 183.29M | 239.24M | 196.50M | 149.18M | 130.13M | 138.12M | 95.25M |
| Income Before Tax Ratio | 2.06% | 1.01% | -3.37% | 7.27% | 12.88% | 7.93% | 7.84% | 13.88% | 14.27% | 12.84% | 13.62% | 15.35% | 14.13% |
| Income Tax Expense | 42.93M | 29.40M | -4.53M | 57.94M | 101.11M | 45.05M | 29.86M | 40.63M | 31.50M | 17.92M | 20.69M | 23.07M | 15.06M |
| Net Income | 106.60M | 41.36M | -269.64M | 378.59M | 373.68M | 186.07M | 155.85M | 200.40M | 164.26M | 130.82M | 108.14M | 113.97M | 80.39M |
| Net Income Ratio | 1.34% | 0.52% | -3.31% | 5.80% | 9.75% | 6.10% | 6.66% | 11.63% | 11.93% | 11.26% | 11.31% | 12.67% | 11.93% |
| EPS | 0.22 | 0.09 | -0.56 | 0.85 | 0.91 | 0.46 | 0.38 | 0.61 | 0.54 | 0.43 | 0.36 | 0.37 | 1.45 |
| EPS Diluted | 0.22 | 0.09 | -0.56 | 0.85 | 0.87 | 0.46 | 0.38 | 0.61 | 0.54 | 0.43 | 0.36 | 0.37 | 1.45 |
| Weighted Avg Shares Out | 484.55M | 485.30M | 483.43M | 443.60M | 411.68M | 403.16M | 405.21M | 328.79M | 305.03M | 302.87M | 304.59M | 305.72M | 486.55M |
| Weighted Avg Shares Out (Dil) | 484.55M | 485.30M | 483.43M | 446.38M | 429.89M | 403.16M | 405.21M | 328.80M | 305.06M | 302.87M | 304.59M | 305.74M | 486.55M |
Source: https://incomestatements.info
Category: Stock Reports